Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3940 (MIR3940)
- Target
- MIR3940
- Molecular classification
- microRNA (miRNA), Non-coding RNA, Post-transcriptional regulator
01
Overview
MicroRNA 3940 (MIR3940) is a small, non-coding RNA found in humans that functions as a post-transcriptional regulator of gene expression. It binds partially complementary sites in the 3’ untranslated regions of target mRNAs, typically resulting in translational repression or mRNA degradation. Like other microRNAs, MIR3940 may play roles in the regulation of physiological and pathological processes, including cellular proliferation, differentiation, and apoptosis, and is under investigation as a potential biomarker and therapeutic target, particularly in oncology and molecular diagnostics[3][2][4].
- Other names
- hsa-mir-3940mir-3940hsa-mir-3940-5pMIR3940
02
Mechanism of action
Inhibition of target mRNA translation or mRNA degradation through partial or perfect sequence complementarity[3] Modulation of specific gene regulatory networks (context and disease-dependent[2][4])
03
Biological functions
Post-transcriptional gene silencingRegulation of mRNA stability and translationCellular homeostasis maintenanceModulation of cell proliferation, differentiation, apoptosis (by analogy to other miRNAs[3][4])
04
Disease associations
Cancer (dysregulation of miRNAs including MIR3940 is linked to various cancers; generalized based on the class, as no specific disease role for MIR3940 is reported in provided text[2][4])Other (potential involvement in other diseases under investigation for miRNAs in general)
05
Safety considerations
Off-target effects and unintended consequences of modulating broad gene networksLimited specificity; miRNAs often target multiple mRNAs and pathwaysDelivery and stability challenges for miRNA therapeutics[4]
06
Biomarkers
Circulating miRNA panel constituents for disease classification, prognosis, or response prediction in cancer and other conditions (MIR3940 may be part of research panels but is not yet a standard clinical biomarker based on current evidence[2][4])
Beyond the preview
Go deeper on MicroRNA 3940 (MIR3940).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 3940 (MIR3940).